24_10_STREAM_SiteHeader_OP

2025 CDMO LEADERSHIP AWARDS CEREMONY

Now in its 14th year, the CDMO Leadership Awards, presented by Outsourced Pharma and brought to you by Life Science Connect with research by Orientation Marketing, highlight the industry’s most valued partners, as determined by the customers who use their services. This year’s awards ceremony introduced new categories and many new winners, based on enhanced scoring methodology, and a refined approach based on customer feedback.

Watch our on-demand broadcast of the event that took place on March 19th, 2025 at The POOL in New York City to share in the celebration of the best in the industry!

 

RECENT WEBINARS

39:56 OneTeam™: Setting a New Standard for Biotech Program Visibility

OneTeam™: Setting A New Standard for Biotech Program Visibility

49:23 Less Risk, More Speed -The New Blueprint for Bioconjugate Development: A Fireside Chat

Less Risk, More Speed -The New Blueprint For Bioconjugate Development

35:23 450_300-img001

Flexible Therapeutic Development: Balancing Speed, Cost, and Process

26:52 Samsung Accel Vector Web

Accelerating Vector Construction-To-IND: Achieving A 9-Month Timeline Through Integrated Cell Line Development

57:58 How AI-Enabled Validation Technologies Enable The Predictive Plant

How AI-Enabled Validation Technologies Enable The Predictive Plant

1:00:26 lonza protein expression webinar

Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems

33:41 Translating Stem Cell Programs To GMP

Translating Stem Cell Programs To GMP

34:07 Catalent Developability Commercial Webinar

Where Biologic Stability Programs Fail — And How ICH Q1 Can Help You Get It Right

49:35 Integrated Thinking for Complex FIH Programs

Integrated Thinking for Complex FIH Programs

1:02:11 Scaling and Manufacturing Semi-Topical Drugs

Concept To Market: Scaling And Manufacturing Semi-Solid Topical Drugs

1:00:45 West-Synchrony-PFS-System

Selecting A Prefillable Syringe System With Confidence

34:05 KBI

Designing Drug Substance Processes For Fill-Finish Compatibility

More Recent Webinars

SMALL MOLECULE OUTSOURCING

2:11 Large-Scale-API-Production-Services-Video

Delivering Commercial Success: Large-Scale API Production Services

58:43 Scientist in lab GettyImages-872025342

From Powder To Particles With Jet Milling

0:54 Solid Formulation: Spray Drying Process

Solid Formulation: Spray Drying Process

4:36 Ross McLellan

Cambrex Scientist Spotlight: Ross McLellan

48:02 GettyImages-1383963898 AI Data

Meeting The Challenge Of Rising API Complexity

1:01:42 Artificial Intelligence Based Screening And Selection Of Co-Formers For Co-Crystallization

AI Based Screening And Selection Of Co-Formers For Co-Crystallization

4:41 Myoung Goo Kim

Cambrex Scientist Spotlight: Myoung Goo Kim

59:36 GettyImages-1687786674 hard_shell pill

Improving Bioavailability, Drug Loads, And Pill Burdens Of Solid Dispersions

31:31 Scientists Mixing Solution In Lab GettyImages-1443286944

Continuous Flow Techniques For Fine Chemical Manufacturing

1:00:17 Lonza-1

Challenges Of Moving A Bioconjugate Candidate From Clinic To Market

31:17 Lonza3

Chromatography, Purification & Isolation Technologies

20:08 Scientists In Lab GettyImages-1291031461

Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders

More Small Molecule Outsourcing Videos

CELL AND GENE OUTSOURCING

22:19 Lonza1

Early Developability And Analytical Toolbox For The Production Of Multi-Chain Biotherapeutics

1:00:36 Comprehensive Cell Solutions CDMO Governance Splash

Quality Agreements: Defining Governance In CDMO Partnerships

1:02 Overcoming pdna challenges

Empowering Your Plasmid DNA Workflow

45:51 GettyImages-166021085 cell and gene

Candidate Screening And Feasibility Studies For Viral Gene Therapies

2:56 Milliporesigma

GLP And The Impact To Start Up Companies

0:44 Meeting Needs And Exceeding Expectations Worldwide

Meeting Needs And Exceeding Expectations Worldwide

52:14 GettyImages-597971944-viral-vector-AAV-adeno-associated-virus

Pioneering Solutions That Turn Hope Into Reality

43:34 Aldevron - CRISPR Genome Editing

CRISPR Genome Editing Solutions From Discovery To Clinic

1:28 Millipore Blazar

The Blazar® Platform In A Minute

3:48 Scientists Discussing GettyImages-916075464

Meet The Experts: Part 4 – Applications And Use Of Raman In Bioprocessing

56:18 Accelerate Your AAV Journey To IND And Beyond

Accelerate Your AAV Journey To IND And Beyond

2:28 GettyImages-597971944-viral-vector-AAV-adeno-associated-virus

A Transformative Journey From Research To Large-Scale Production

More Cell and Gene Outsourcing Videos

OUTSOURCED PHARMA CAPACITY UPDATE

19:29 Minaris Advanced Therapies Capabilities Update March 2026: Cell & Gene Therapy

Minaris Advanced Therapies Capabilities Update March 2026: Cell & Gene Therapy

22:28 Lonza Capabilities Update March 2026: Cell & Gene Therapy

Lonza Capabilities Update March 2026: Cell & Gene Therapy

17:22 Landmark Bio Capabilities Update March 2026: Cell & Gene Therapy

Landmark Bio Capabilities Update March 2026: Cell & Gene Therapy

17:16 Comprehensive Cell Solutions Capabilities Update March 2026: Cell & Gene Therapy

Comprehensive Cell Solutions Capabilities Update March 2026: Cell & Gene Therapy

16:45 cytovance large mol opcu march 26

Cytovance Biologics Capabilities Update March 2026: Large Molecule

9:57 ElevateBio OPCU March 26

ElevateBio Capabilities Update March 2026: Cell & Gene Therapy

20:12 Quotient Smol March 2026

Quotient Sciences Capabilities Update March 2026: Small Molecule Drug Product

12:53 pfizer smol march 2026

Pfizer CentreOne Capabilities Update March 2026: Small Molecule Drug Product

21:31 PCI Smol March 2026

PCI Pharma Services Capabilities Update March 2026: Small Molecule Drug Product

17:27 Mikart Smol March 2026

Mikart Capabilities Update March 2026: Small Molecule Drug Product

17:26 Asymchem March 2026

Asymchem Capabilities Update March 2026: Small Molecule Drug Product

15:42 SK Small Mole March 2026

SK Pharmteco Capabilities Update March 2026: Small Molecule Drug Substance

Outsourced Pharma Capacity Update Page

BIOLOGIC OUTSOURCING

17:49 Bio-Expo Live

Real-Time Monitoring And Automated Sampling For Enhanced Efficiency

1:02 Overcoming pdna challenges

Empowering Your Plasmid DNA Workflow

20:54 OP Capacity Update

Reducing CMC Risk With Proven Analytical And Formulation Expertise

1:07 A Targeted Molecular Method For Sensitive Viral Detection In Just Days

A Targeted Molecular Method For Sensitive Viral Detection In Just Days

1:35 Ampoule Aseptic Filling GettyImages-1490244818

Delivering Top Quality Fill Finish Manufacturing

2:56 Milliporesigma

GLP And The Impact To Start Up Companies

0:44 Meeting Needs And Exceeding Expectations Worldwide

Meeting Needs And Exceeding Expectations Worldwide

1:28 Millipore Blazar

The Blazar® Platform In A Minute

3:48 Scientists Discussing GettyImages-916075464

Meet The Experts: Part 4 – Applications And Use Of Raman In Bioprocessing

1:56 Biotherapy Characterization: Binding Assays

Biotherapy Characterization: Binding Assays

15:33 Bio-Expo Live

MilliporeSigma Bio-Expo Live February 2025: Downstream Bioprocessing

1:02 Optimize Downstream For Your mRNA Template

Streamline Your mRNA Purification Steps

More Biologic Outsourcing Videos

OUTSOURCED PHARMA LIVE

3:12 Defining Clinical Supply Resilience

Defining Clinical Supply Resilience

6:49 The Reality of AI in Clinical Supplies

The Reality of AI in Clinical Supplies

2:52 Becoming a Client of Choice for CDMOs

Becoming a Client of Choice for CDMOs

3:53 The Recovery Playbook for Site Disruptions

The Recovery Playbook for Site Disruptions

3:08 Pandemic Lessons and Vendor Partnerships

Pandemic Lessons and Vendor Partnerships

59:21 Clinical Supply Chain Therapy: Lowering Risk (And Your Blood Pressure)

Clinical Supply Chain Therapy: Lowering Risk (And Your Blood Pressure)

4:09 The One Quality Metric That Actually Matters

The One Quality Metric That Actually Matters

3:08 Navigating Private Equity Ownership in the CDMO Space

Navigating Private Equity Ownership In The CDMO Space

1:25 What Great CDMO Selection Looks Like In 2026

What Great CDMO Selection Looks Like In 2026

2:48 The "Bad News" Stress Test: How CDMOs Handle Escalation

The "Bad News" Stress Test: How CDMOs Handle Escalation

4:49 The BioSecure Act & Unfiltered Supply Chain Realities

The BioSecure Act And Unfiltered Supply Chain Realities

1:00:53 The Unfiltered Truth About CDMO Selection

The Unfiltered Truth About CDMO Selection

Outsourced Pharma Live Page

OUTSOURCING FUNDAMENTALS

1:35 Ampoule Aseptic Filling GettyImages-1490244818

Delivering Top Quality Fill Finish Manufacturing

1:01:52 Selecting a cdmo

Selecting A CDMO: A Guide To Successful Collaboration

0:30 Scientist in lab GettyImages-872025342

Collaborating To Craft Efficient Processes

1:13 23_10_OPL_Challenges_Webinar_Seg01

Workforce Challenges Key To Outsourcing

4:15 23_10_OPL_Challenges_Webinar_Seg02

Managing Multiple Partners – And Materials – From Around The Globe

0:30 GettyImages-1413600685-lab-team-collaboration-computer-research

Visionary Thinkers And Problem Solvers: The Cambrex Team

0:30 GettyImages-1146473276-team-collaboration-partnership-discussion

Fostering CDMO Collaboration On Both Sides

2:30 West-Feature-PFS SYRG-0178 NovaPure

Consistent, Reliable, High-Quality Components

More Outsourcing Fundamentals Videos

BUSINESS OF BIOTECH

58:36 Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.

Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.

40:29 Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor

Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor

55:44 Investing In Early-Stage Oncology With Yosemite's Dan McHugh

Investing In Early-Stage Oncology With Yosemite's Dan McHugh

51:00 Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash

Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash

54:03 Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.

Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.

48:33 Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.

Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.

54:00 Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.

Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.

58:19 An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.

An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.

56:56 Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer

Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer

42:39 Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie

Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie

44:38 BoB@JPM: Brian Hilberdink, Boehringer Ingelheim

BoB@JPM: Brian Hilberdink, Boehringer Ingelheim

56:00 BoB@JPM: Ron Cooper, enGene

BoB@JPM: Ron Cooper, enGene

36:08 BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics

BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics

58:44 A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith

A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith

1:21:11 Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead

Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead

46:43 Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos

Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos

55:39 Modernizing Clinical Trial Operations With Merck's Jennifer Sheller

Modernizing Clinical Trial Operations With Merck's Jennifer Sheller

55:39 Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.

Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.

53:54 Engineering B Cells With Immusoft's Sean Ainsworth

Engineering B Cells With Immusoft's Sean Ainsworth

51:32 Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt

Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt

58:44 Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

57:04 BoB_1280x720_Allan_Shaw

Biotech Funding And IPO Temperature Check With CREATE Medicine's Allan Shaw

46:14 Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier

Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier

42:51 Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.

Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.

31:47 BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals

BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals

33:34 BoB In South Florida: Anthony Japour, M.D., iTolerance

BoB In South Florida: Anthony Japour, M.D., iTolerance

33:08 BoB In South Florida: Daniel Teper, NAYA Therapeutics

BoB In South Florida: Daniel Teper, NAYA Therapeutics

34:58 BoB In South Florida: Raquel Cabo, Miami Biotech Collective

BoB In South Florida: Raquel Cabo, Miami Biotech Collective

57:58 The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott

The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott

57:27 Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham

Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham

58:25 Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

57:54 Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.

Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.

1:04:36 Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.

Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.

52:07 BoB_1280x720_Vladimir_Cmiljanovic

Building A Biotech Incubator And Accelerator With Swiss Rockets Founder And CEO Vladimir Cmiljanovic, Ph.D.

52:37 Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia

Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia

58:11 How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak

How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak

52:03 The Generalist Biotech CEO With Seekyo's Oury Chetboun

The Generalist Biotech CEO With Seekyo's Oury Chetboun

54:07 BoB_1280x720_Ebrahim_Delpassand

Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.

45:41 BoB_1280x720_Ep263

Building An Efficient Biopharma With South Rampart Pharma's Hernan Bazan, M.D.

54:23 24_01_BoB_1280x720_Ep262

The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics

32:40 24_01_BoB_1280x720_Ep261

BoB Live At BIO: Amber Salzman, Ph.D., Epicrispr Biotechnologies

56:34 24_01_BoB_1280x720_Ep260

How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland

1:04:33 24_01_BoB_1280x720_Ep259

FDA Trials And Tribulations With Connect Biopharma's Barry Quart

58:23 24_01_BoB_1280x720_Ep258_2

Proactive Procurement Strategies For Biotech With Tom Wells

1:06:27 24_01_BoB_1280x720_Ep257

The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson

55:50 24_01_BoB_1280x720_Ep256

Psychedelics For Mental Health Disorders With atai's Srinivas Rao, M.D., Ph.D.

56:27 24_01_BoB_1280x720_Ep255

Biotech Angel Investing With Yaniv Sneor

59:23 24_01_BoB_1280x720_Ep254

Leading A tRNA Startup With Alltrna's Michelle Werner

39:45 24_01_BoB_1280x720_Ep253

Executing A Product Pivot With Vir's Mark Eisner, MD

55:54 24_01_BoB_1280x720_Ep252

Commercializing RNAi Therapies With Alnylam's Tolga Tanguler

55:45 24_01_BoB_1280x720_Ep251

Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie

46:08 24_01_BoB_1280x720_Ep250

The Implications Of China's Growing Biotech Industry With Allan Shaw

44:20 24_01_BoB_1280x720_Ep249

How To Be A CFO With Insmed's Sara Bonstein

46:43 24_01_BoB_1280x720_Ep248

Deal And Investment Trends With Investment Banker David Sans

34:44 24_01_BoB_1280x720_Ep247

Business of Biotech 2.0 with Ben Comer

43:32 24_01_BoB_1280x720_Ep246

BoB@JPM: Nima Farzan, Latigo Biotherapeutics

43:46 24_01_BoB_1280x720_Ep245

BoB@JPM: Kasper Roet, Ph.D., QurAlis

52:20 24_01_BoB_1280x720_Ep244

BoB@JPM: Rick Modi, Affinia Therapeutics

56:27 24_01_BoB_1280x720_Ep243

BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty

47:59 24_01_BoB_1280x720_Ep242

BoB@JPM: Tom Chalberg, Ph.D., Genascence

37:00 24_01_BoB_1280x720_Ep241

BoB@JPM: Ran Zheng, Landmark Bio

45:07 24_01_BoB_1280x720_Ep240

BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics

43:00 24_01_BoB_1280x720_Ep239

BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience

47:50 24_01_BoB_1280x720_Ep238

The Business Of CNS with Acumen's Jim Doherty, Ph.D.

1:13:36 24_01_BoB_1280x720_Ep237

High-Throughput Discovery With BIOPTIC's Andrey Dobry

1:06:32 24_01_BoB_1280x720_Ep236

RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.

54:04 24_01_BoB_1280x720_Ep235

Biotech Story Time With Tal Zaks, M.D. (Part 2)

1:02:34 24_01_BoB_1280x720_Ep234

Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.

55:25 24_01_BoB_1280x720_Ep233

Biotech Story Time With Tal Zaks, M.D. (Part 1)

52:50 24_01_BoB_1280x720_Ep232

A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.

1:03:50 24_01_BoB_1280x720_Ep231

Manufacturing Partnership With Life Biosciences Jerry McLaughlin and Forge Biologics' John Maslowski

45:26 24_01_BoB_1280x720_Ep230

Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.

49:54 24_01_BoB_1280x720_Ep229

Biopolitics With Allan Shaw

1:01:35 24_01_BoB_1280x720_Ep228

T-Cells For The Win With Adaptimmune's Adrian Rawcliffe

46:48 24_01_BoB_1280x720_Ep227

Serving The Underserved With Gates MRI's Claire Wagner, M.D.

49:12 24_01_BoB_1280x720_Ep226

An Unanticipated Biotech Startup With OS Therapies' Paul Romness

44:14 24_01_BoB_1280x720_Ep225

Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright

1:02:40 24_01_BoB_1280x720_Ep224

Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

51:34 24_01_BoB_1280x720_Ep223

Biotech C-Suite Construction With Allan Shaw

59:19 24_01_BoB_1280x720_Ep222

The Peptide Promise With NervGen's Mike Kelly

1:17:16 24_01_BoB_1280x720_Ep221

Biotech Course Correction With Treehill Partners' Ali Pashazadeh

1:14:26 24_01_BoB_1280x720_Ep220

An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.

54:05 24_01_BoB_1280x720_Ep218

Embracing Biotech Chaos With Memo's Erik van den Berg

1:04:47 24_01_BoB_1280x720_Ep217

Pivoting To RNA With Circio's Dr. Erik Digman Wiklund

1:03:07 24_01_BoB_1280x720_Ep216

mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D.

58:06 24_01_BoB_1280x720_Ep215

Steering Through Setbacks with AVEO Oncology's Michael Bailey

59:37 24_01_BoB_1280x720_Ep214

Leading From Within with ISCT & Kiji's Miguel Forte, M.D.

56:38 24_01_BoB_1280x720_Ep212

Expanding The Proteome with ProFound's John Lepore, M.D.

1:06:39 24_01_BoB_1280x720_Ep211

From The Bench To The Boardroom with ImmunityBio's Enrique Diloné

1:08:52 24_01_BoB_1280x720_Ep210

First AI Antibody In Humans with Aulos' Aron Knickerbocker

1:12:31 24_01_BoB_1280x720_Ep209

Drug Delivery Differentiators with Syncromune's Eamonn Hobbs

58:06 24_01_BoB_1280x720_Ep208

Topical Ocular Biologics with Claris Bio's Clarke Atwell

1:04:08 24_01_BoB_1280x720_Ep206

True DEI Value in Biopharma with Arcellx's Rami Elghandour

22:57 BoB_Ep204_Ch02

How Daiichi Sankyo Revitalized ADCs

55:45 24_01_BoB_1280x720_Ep205

Mission-Driven Dementia Funding with DDF's Jonathan Behr

26:07 BoB_Ep203_Ch02

How Is Mythic Therapeutics Transforming The ADC Space?

1:04:06 24_01_BoB_1280x720_Ep204

ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller

56:38 24_01_BoB_1280x720_Ep203

Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.

12:15 BoB_Ep196_Ch04

What's Next For Ampersand Biomedicines?

12:15 BoB_Ep196_Ch03

Marrying Computational Biology To Biotech Science

Business of Biotech Page

CELL & GENE PODCAST

20:49 Advancing Early Detection in Rare Cancers with Catriona Jamieson, M.D., Ph.D.

Advancing Early Detection in Rare Cancers with Catriona Jamieson, M.D., Ph.D.

27:20 Regulatory Flexibility in CGT: Key Shifts and Implications with Monika Swietlicka

Regulatory Flexibility in CGT: Key Shifts and Implications with Monika Swietlicka

28:04 Scaling CRISPR for Rare Disease with Aurora Therapeutics' Dr. Edward Kaye

Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye

34:27 Simplifying Friction in Cell Therapy Clinical Trials with Dr. Panteli Theocharous

Simplifying Friction in Cell Therapy Clinical Trials with Dr. Panteli Theocharous

14:23 Inside a Breakthrough HER2 Immunotherapy for PMO with OS Therapies’ Paul Romness

Inside a Breakthrough HER2 Immunotherapy for PMO with OS Therapies' Paul Romness

30:03 Building Safer CRISPR Medicines for CVD with Scribe Therapeutics' Benjamin Oakes

Building Safer CRISPR Medicines for CVD with Scribe Therapeutics' Benjamin Oakes

19:35 Advancing Off-the-Shelf CRISPR CAR-T Therapies into the Community Setting with Caribou Biosciences' Rachel Haurwitz

Advancing Off-The-Shelf CRISPR CAR-T Therapies Into The Community Setting With Caribou Biosciences' Rachel Haurwitz

1:22:27 The Editors' Roundtable: A 2025 Retrospective of the Life Sciences Industry

The Editors' Roundtable: A 2025 Retrospective of the Life Sciences Industry

21:08 Developing Itvisma for Broad-Range Treatment of SMA with Novartis' Dr. Norman Putzki

Developing Itvisma for Broad-Range Treatment of SMA with Novartis' Dr. Norman Putzki

16:28 Turning the Tumor Microenvironment Against Cancer with MGB's Alexander Cryer, Ph.D.

Turning the Tumor Microenvironment Against Cancer with MGB's Alexander Cryer, Ph.D.

18:21 Building Patient-Driven Culture and Leadership Resilience in CGT with Paul Perreault

Building Patient-Driven Culture and Leadership Resilience in CGT with Paul Perreault

26:59 Treating Inherited Retinal Disorders with Ocugen's Dr. Arun Upadhyay

Treating Inherited Retinal Disorders with Ocugen's Dr. Arun Upadhyay

More Cell & Gene Podcast Videos

MOST RECENT OUTSOURCED PHARMA LIVE VIDEO

3:12 Defining Clinical Supply Resilience
Defining Clinical Supply Resilience

This segment of the Outsourced Pharma Live event, "Clinical Supply Therapy: Lowering Risk and Your Blood Pressure," addresses the true meaning of resilience in the clinical supply chain.